Josh Mandel-Brehm
Director; Director, Chief Executive Officer · 3 filings · Latest: Aug 3, 2026
Camp4 Therapeutics Corp
ProMIS Neurosciences Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CAMP | Josh Mandel-Brehm | Director, Chief Executive Officer | Aug 3, 2026 | Purchase | $1.65 | 6,551 | $10.8K | 284,968 |